Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €1.06 EUR
Change Today +0.157 / 17.35%
Volume 708.0
RYIN On Other Exchanges
As of 3:40 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - sunesis pharmaceuticals inc (RYIN)

NameBoard RelationshipsTitleAge
Daniel N. Swisher Jr.28 RelationshipsChief Executive Officer, President and Director52
Eric H. Bjerkholt 24 RelationshipsChief Financial Officer, Executive Vice President of Corporate Development & Finance and Corporate Secretary55
Adam R. Craig M.D., Ph.D., M.B.A.No RelationshipsChief Medical Officer and Executive Vice President of Development49

Board Members - sunesis pharmaceuticals inc (RYIN)

NameBoard RelationshipsPrimary CompanyAge
James W. Young Ph.D.42 Relationships5AM Venture Management LLC70
Daniel N. Swisher Jr.28 RelationshipsSunesis Pharmaceuticals, Inc.52
Matthew K. Fust 40 RelationshipsSunesis Pharmaceuticals, Inc.50
Homer L. Pearce Ph.D.74 RelationshipsPearl Street Venture Funds62
Dayton Misfeldt 29 RelationshipsBay City Capital LLC41

Executive Committees* - sunesis pharmaceuticals inc (RYIN)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeMatthew K. Fust 40 Relationships3 Executives
Compensation CommitteeDayton Misfeldt 29 Relationships3 Executives
Nominating CommitteeHomer L. Pearce Ph.D. 74 Relationships2 Executives
Corporate Governance CommitteeHomer L. Pearce Ph.D. 74 Relationships2 Executives
View RYIN Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RYIN:GR €1.06 EUR +0.157

RYIN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
NeurogesX Inc $0.0065 USD 0.00
POZEN Inc $8.85 USD +0.02
View Industry Companies

Industry Analysis


Industry Average

Valuation RYIN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 21.6x
Price/Book 4.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 8.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SUNESIS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at